Literature DB >> 1371123

Physicochemical and physiological properties of cholylsarcosine. A potential replacement detergent for bile acid deficiency states in the small intestine.

J Lillienau1, C D Schteingart, A F Hofmann.   

Abstract

The properties of cholylsarcosine (the synthetic N-acyl conjugate of cholic acid with sarcosine [N-methylglycine]) were examined to determine its suitability as a bile acid replacement agent for conditions of bile acid deficiency in the small intestine, which causes fat malabsorption. Previous studies in rodents had shown that the compound was well transported by the liver and ileum and underwent neither deconjugation nor dehydroxylation during enterohepatic cycling. By 1H-nuclear magnetic resonance, cholylsarcosine was found to exist in dilute aqueous solution as an almost equimolar mixture of two geometric isomers--cis and trans (around the amide bond)--in contrast to cholylglycine, which was present entirely in the trans form. The critical micellization concentration was 11 mmol/liter, similar to that of cholylglycine (10 mmol/liter). By nonaqueous titrimetry, the pKa' of cholylsarcosine was 3.7, only slightly lower than that of cholylglycine (3.9). Cholylsarcosine was poorly soluble below pH 3.7, but highly soluble above pH 4. In vitro, cholylsarcosine behaved as cholylglycine with respect to promoting lipolysis by lipase/colipase. There was little difference between cholylsarcosine and cholylglycine in their solubilization of an equimolar mixture of oleic acid, oleate, and monoolein (designed to simulate digestive products of triglyceride) or in their solubilization of monooleyl-glycerol alone. When a [3H]triolein emulsion with either cholylsarcosine or cholyltaurine was infused intraduodenally in biliary fistula rats, recovery of 3H in lymph was 52 +/- 10% (mean +/- SD) for cholylsarcosine and 52 +/- 11% for cholyltaurine. When perfused into the colon of the anesthetized rabbit, cholylsarcosine (5 mmol/liter) did not influence water absorption or permeability to erythritol, in contrast to chenodeoxycholate, which induced vigorous water secretion and caused erythritol loss. We conclude that cholylsarcosine possesses the physicochemical and physiological properties required for a suitable bile acid replacement in deficiency states.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371123      PMCID: PMC442868          DOI: 10.1172/JCI115601

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  39 in total

1.  Nuclear magnetic resonance studies of the acid-base chemistry of amino acids and peptides. II. Dependence of the acidity of the C-terminal carboxyl group on the conformation of the C-terminal peptide bond.

Authors:  C A Evans; D L Rabenstein
Journal:  J Am Chem Soc       Date:  1974-11-13       Impact factor: 15.419

2.  Bile-salts in small intestinal contents after ileal resection and in other malabsorption syndromes.

Authors:  G M McLeod; H S Wiggins
Journal:  Lancet       Date:  1968-04-27       Impact factor: 79.321

3.  Role of bile acid malabsorption in pathogenesis of diarrhea and steatorrhea in patients with ileal resection. I. Response to cholestyramine or replacement of dietary long chain triglyceride by medium chain triglyceride.

Authors:  A F Hofmann; J R Poley
Journal:  Gastroenterology       Date:  1972-05       Impact factor: 22.682

4.  Transport, metabolism, and effect of chronic feeding of cholylsarcosine, a conjugated bile acid resistant to deconjugation and dehydroxylation.

Authors:  A Schmassmann; M A Angellotti; H T Ton-Nu; C D Schteingart; S N Marcus; S S Rossi; A F Hofmann
Journal:  Gastroenterology       Date:  1990-01       Impact factor: 22.682

5.  Importance of bile acids and of an intact distal small intestine for fat absorption.

Authors:  W I Austad; L Lack; M P Tyor
Journal:  Gastroenterology       Date:  1967-04       Impact factor: 22.682

6.  Influence of individual bile acids in Escherichia coli peritonitis.

Authors:  R Andersson; K G Tranberg; J Lillienau; C Schalén; U Srinivas; L Larsson; A Sonesson; S Bengmark
Journal:  Scand J Gastroenterol       Date:  1990-11       Impact factor: 2.423

7.  One- and two-dimensional NMR relaxation studies of dynamics and structure in bile salt-phosphatidylcholine mixed micelles.

Authors:  R E Stark; R W Storrs; S E Levine; S Yee; M S Broido
Journal:  Biochim Biophys Acta       Date:  1986-08-21

8.  Colonic secretion of water and electrolytes induced by bile acids: perfusion studies in man.

Authors:  H S Mekjian; S F Phillips; A F Hofmann
Journal:  J Clin Invest       Date:  1971-08       Impact factor: 14.808

9.  High pressure liquid chromatographic analysis of conjugated bile acids in human bile: simultaneous resolution of sulfated and unsulfated lithocholyl amidates and the common conjugated bile acids.

Authors:  S S Rossi; J L Converse; A F Hofmann
Journal:  J Lipid Res       Date:  1987-05       Impact factor: 5.922

10.  Bile salt deficiency and the absorption of vitamin D metabolites. In vivo study in the rat.

Authors:  M Maislos; S Shany
Journal:  Isr J Med Sci       Date:  1987-11
View more
  12 in total

1.  Cholylsarcosine for bile acid deficiency caused by ileal resection.

Authors:  O S Popović; N Jojić; D Necić
Journal:  Dig Dis Sci       Date:  1999-09       Impact factor: 3.199

Review 2.  Clinical pharmacokinetics of therapeutic bile acids.

Authors:  A Crosignani; K D Setchell; P Invernizzi; A Larghi; C M Rodrigues; M Podda
Journal:  Clin Pharmacokinet       Date:  1996-05       Impact factor: 6.447

3.  Oral delivery of ionic complex of ceftriaxone with bile acid derivative in non-human primates.

Authors:  Ok-Cheol Jeon; Seung Rim Hwang; Taslim A Al-Hilal; Jin Woo Park; Hyun Tae Moon; Seulki Lee; Jae Hyung Park; Youngro Byun
Journal:  Pharm Res       Date:  2013-01-05       Impact factor: 4.200

4.  [N-methyl-11C]cholylsarcosine, a novel bile acid tracer for PET/CT of hepatic excretory function: radiosynthesis and proof-of-concept studies in pigs.

Authors:  Kim Frisch; Steen Jakobsen; Michael Sørensen; Ole Lajord Munk; Aage K O Alstrup; Peter Ott; Alan F Hofmann; Susanne Keiding
Journal:  J Nucl Med       Date:  2012-03-27       Impact factor: 10.057

5.  Bile Acid malabsorption.

Authors:  Henrik Westergaard
Journal:  Curr Treat Options Gastroenterol       Date:  2007-02

6.  Characterisation of patients with a complete biochemical response to ursodeoxycholic acid.

Authors:  R A Jorgensen; E R Dickson; A F Hofmann; S S Rossi; K D Lindor
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

7.  Effect of replacement therapy with cholylsarcosine on fat malabsorption associated with severe bile acid malabsorption. Studies in dogs with ileal resection.

Authors:  S J Longmire-Cook; J Lillienau; Y S Kim; C D Schteingart; R G Danzinger; O Esch; A F Hofmann
Journal:  Dig Dis Sci       Date:  1992-08       Impact factor: 3.199

8.  Adjuvant cholylsarcosine during ursodeoxycholic acid treatment of primary biliary cirrhosis.

Authors:  P Ricci; A F Hofmann; L R Hagey; R A Jorgensen; E Rolland Dickson; K D Lindor
Journal:  Dig Dis Sci       Date:  1998-06       Impact factor: 3.199

9.  Design and evaluation of a novel trifluorinated imaging agent for assessment of bile acid transport using fluorine magnetic resonance imaging.

Authors:  Diana Vivian; Kunrong Cheng; Sandeep Khurana; Su Xu; Paul A Dawson; Jean-Pierre Raufman; James E Polli
Journal:  J Pharm Sci       Date:  2014-09-05       Impact factor: 3.534

Review 10.  Key discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decades.

Authors:  Alan F Hofmann; Lee R Hagey
Journal:  J Lipid Res       Date:  2014-05-17       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.